The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
Open accessAbstract
BACKGROUND: Optimal antibiotic treatment for sepsis is imperative. Combining a beta lactam antibiotic with an aminoglycoside antibiotic may provide certain advantages over beta lactam monotherapy. OBJECTIVES: Our objectives were to compare beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy in patients with sepsis and to estimate the rate of adverse effects with each treatment regimen, including the development of bacterial resistance to antibiotics. SEARCH METHODS: In this updated review, we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 11); MEDLINE (1966 to 4 November 2013); EMBASE (1980 to November 2013); LILACS (1982 to November 2013); and conference proceedings of the Interscience Conference of Antimicrobial Agents and Chemotherapy (1995 to 2013). We scanned citations of all identified studies and contacted all corresponding authors. In our previous review, we searched the databases to July 2004. SELECTION CRITERIA: We included randomized and quasi-randomized trials comparing any beta lactam monotherapy versus any combination of a beta lactam with an aminoglycoside for sepsis. DATA COLLECTION AND ANALYSIS: The primary outcome was all-cause mortality. Secondary outcomes included treatment failure, superinfections and adverse events. Two review authors independently collected data. We pooled risk ratios (RRs) with 95% confidence intervals (CIs) using the fixed-effect model. We extracted outcomes by intention-to-treat analysis whenever possible. MAIN RESULTS: We included 69 trials that randomly assigned 7863 participants. Twenty-two trials compared the same beta lactam in both study arms, while the remaining trials compared different beta lactams using a broader-spectrum beta lactam in the monotherapy arm. In trials comparing the same beta lactam, we observed no difference between study groups with regard to all-cause mortality (RR 0.97, 95% CI 0.73 to 1.30) and clinical failure (RR 1.11, 95% CI 0.95 to 1.29). In studies comparing different beta lactams, we observed a trend for benefit with monotherapy for all-cause mortality (RR 0.85, 95% CI 0.71 to 1.01) and a significant advantage for clinical failure (RR 0.75, 95% CI 0.67 to 0.84). No significant disparities emerged from subgroup and sensitivity analyses, including assessment of participants with Gram-negative infection. The subgroup of Pseudomonas aeruginosa infections was underpowered to examine effects. Results for mortality were classified as low quality of evidence mainly as the result of imprecision. Results for failure were classified as very low quality of evidence because of indirectness of the outcome and possible detection bias in non-blinded trials. We detected no differences in the rate of development of resistance. Nephrotoxicity was significantly less frequent with monotherapy (RR 0.30, 95% CI 0.23 to 0.39). We found no heterogeneity for all these comparisons.We included a small subset of studies addressing participants with Gram-positive infection, mainly endocarditis. We identified no difference between monotherapy and combination therapy in these studies. AUTHORS' CONCLUSIONS: The addition of an aminoglycoside to beta lactams for sepsis should be discouraged. All-cause mortality rates are unchanged. Combination treatment carries a significant risk of nephrotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Principles and Practice of Infectious Diseases.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-1-169_2 · Cited by 1,564
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Diagnosis and Management of Infective Endocarditis and Its Complications
Bayer, A. S., Bolger, A. F., Taubert, K. A., Wilson, W., Steckelberg, J., Karchmer, A. W., Levison, M., Chambers, H. F., Dajani, A. S., Gewitz, M. H., et al. (1998) · Circulation · doi:10.1161/01.cir.98.25.2936 · Cited by 759
The ACCP-SCCM Consensus Conference on Sepsis and Organ Failure
Bone, R. C., Sibbald, W. J., & Sprung, C. L. (1992) · Chest · doi:10.1378/chest.101.6.1481 · Cited by 738
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
Self-citationThe benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Self-citationKumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Single or multiple daily doses of aminoglycosides: a meta-analysis
Barza, M., Ioannidis, J. P., Cappelleri, J. C., & Lau, J. (1996) · BMJ · doi:10.1136/bmj.312.7027.338 · Cited by 450
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e96b91 · Cited by 340
Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe Infections
Felisart, J., Rimola, A., Arroyo, V., Perez-Ayuso, R. M., Quintero, E., Gines, P., & Rodes, J. (1985) · Hepatology · doi:10.1002/hep.1840050319 · Cited by 303
Factors Affecting Mortality of Gram-Negative Rod Bacteremia
Bryant, R. E. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.127.1.120 · Cited by 298
Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H., & Pitlik, S. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1127 · Cited by 280
Self-citationBliziotis, I. A., Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S., & Falagas, M. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430912 · Cited by 219
Paul, M., Andreassen, S., Tacconelli, E., Nielsen, A. D., Almanasreh, N., Frank, U., Cauda, R., & Leibovici, L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl372 · Cited by 214
Self-citationCometta, A., Baumgartner, J. D., Lew, D., Zimmerli, W., Pittet, D., Chopart, P., Schaad, U., Herter, C., Eggimann, P., & Huber, O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1309 · Cited by 202
Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group (1998) · Clinical Infectious Diseases · doi:10.1086/515038 · Cited by 195
Ribera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187
Changing pattern of organ dysfunction in early human sepsis is related to mortality
Russell, J. A., Singer, J., Bernard, G. R., Wheeler, A., Fulkerson, W., Hudson, L., Schein, R., Summer, W., Wright, P., & Walley, K. R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200010000-00005 · Cited by 182
Paul, M., Dickstein, Y., Schlesinger, A., Grozinsky-Glasberg, S., Soares-Weiser, K., & Leibovici, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038.pub2 · Cited by 177
Self-citationDevelopment of resistance during antibiotic therapy
Milatovic, D., & Braveny, I. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02017607 · Cited by 174
Pragmatic randomised trials using routine electronic health records: putting them to the test
Staa, T.-P. V., Goldacre, B., Gulliford, M., Cassell, J., Pirmohamed, M., Taweel, A., Delaney, B., & Smeeth, L. (2012) · BMJ · doi:10.1136/bmj.e55 · Cited by 169
Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus
Sande, M. A., & Johnson, M. L. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.4.367 · Cited by 158
Synergistic Combinations of Antibiotics in Gram-Negative Bacillary Infections
Klastersky, J., & Zinner, S. H. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.294 · Cited by 158
Falagas, M. E., Matthaiou, D. K., & Bliziotis, I. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl044 · Cited by 147
Paul, M., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 145
Self-citationSmith, A. L., Doershuk, C. F., Goldmann, D. A., Gore, E., Hilman, B. C., Marks, M. I., Moss, R. B., Ramsey, B. W., Redding, G. J., Rubio, T. T., et al. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70197-6 · Cited by 140
Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers
ABRAMS, B., SKLAVER, A., HOFFMAN, T., & Greenman, R. L. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-5-789 · Cited by 125
SIEGER, B. E., Berman, S., Geckler, R. W., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199710000-00015 · Cited by 124
McLaughlin, F. J., Matthews, W. J., Strieder, D. J., Sullivan, B., Taneja, A., Murphy, P. G., & Goldmann, D. A. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.3.559 · Cited by 124
Dupont, H., Carbon, C., & Carlet, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2028-2033.2000 · Cited by 120
Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
Ma, S., & Kb, C. (1976) · PubMed · Cited by 119
Giamarellou, H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90490-0 · Cited by 118
The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients
Thompson, S. E., Hager, W. D., Wong, K.-H., et al. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90592-x · Cited by 115
Penicillin-Aminoglycoside Synergy in Experimental Streptococcus viridans Endocarditis
Sande, M. A., & Irvin, R. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.5.572 · Cited by 115
Gribble, M. J., CHOW, A. W. C., Naiman, S. C., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.388 · Cited by 113
Broad spectrum penicillin as an adequate therapy for acute cholangitis.
Thompson, J. E., Pitt, H. A., Doty, J. E., Coleman, J. W., & Irving, C. (1990) · PubMed · Cited by 93
Watanakunakorn, C., & Baird, I. M. (1977) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197703000-00002 · Cited by 88
Rubinstein, E., Lode, H. M., Grassi, C., & Antibiotic Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1217 · Cited by 85
Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
Marcus, R., Paul, M., Elphick, H., & Leibovici, L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.029 · Cited by 84
Self-citationA Randomized Trial of Three Antibiotic Regimens for the Treatment of Pyelonephritis in Pregnancy
Wing, D. A., HENDERSHOTT, C. M., DEBUQUE, L., & MILLAR, L. K. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00156-2 · Cited by 82
Gold, R., OVERMEYER, A., KNIE, B., Fleming, P. C., & Levison, H. (1985) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198503000-00012 · Cited by 74
Pneumonia Due to Pseudomonas aeruginosa
Sun, H., Fujitani, S., Quintiliani, R., & Yu, V. L. (2011) · CHEST Journal · doi:10.1378/chest.10-0167 · Cited by 73
Efficacy of Meropenem as Monotherapy in the Treatment of Ventilator-Associated Pneumonia
Lerma, F. Á., & On Behalf of The Serious Infection Study Group (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.1.70 · Cited by 72
Álvarez-Lerma, F., Insausti-Ordeñana, J., Jordà‐Marcos, R., et al. (2001) · Intensive Care Medicine · doi:10.1007/s001340000846 · Cited by 70
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Elphick, H., & Jahnke, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub3 · Cited by 66
Empirical monotherapy with meropenem in serious bacterial infections
Mouton, Y., Beuscart, C., & the Meropenem Study Group (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.suppl_a.145 · Cited by 62
Antibiotics in infections of the biliary tract.
Muller, E. L., Pitt, H. A., Thompson, J. J., Doty, J. E., Mann, L. L., & Manchester, B. (1987) · PubMed · Cited by 60
Gerecht, W. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.6.1279 · Cited by 57
Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia
Mangi, R. J., Greco, T., Ryan, J. L., Thornton, G. F., & Andriole, V. T. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90010-1 · Cited by 56
Klastersky, J. A., Meunier-Carpentier, F., Prevost, J., & Staquet, M. J. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/134.3.271 · Cited by 53
Combination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses
Paul, M., & Leibovici, L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.01.004 · Cited by 53
Self-citationEMPIRIC MONOTHERAPY VERSUS COMBINATION THERAPY OF NOSOCOMIAL PNEUMONIA IN TRAUMA PATIENTS
Croce, M. A., Fabian, T. C., Stewart, R. M., et al. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199308000-00022 · Cited by 47
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Elphick, H., & Tan, A. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub2 · Cited by 47
Paul, M., Schlesinger, A., Grozinsky‐Glasberg, S., et al. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003038 · Cited by 47
Self-citationDamas, P., Garweg, C., Monchi, M., Nys, M., Canivet, J.-L., Ledoux, D., & Preiser, J. (2006) · Critical Care · doi:10.1186/cc4879 · Cited by 44
Hoepelman, I. M., Rozenberg-Arska, M., & Verhoef, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92121-6 · Cited by 42
Ciprofloxacin Study Group, Krumpe, P. E., Cohn, S. M., Garreltes, J., Ramírez, J. A., Coulter, H., Haverstock, D. C., & ECHOLS, R. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.117 · Cited by 38
Meropenem versus Cefuroxime plus Gentamicin for Treatment of Serious Infections in Elderly Patients
Jaspers, C. A. J. J., Kieft, H., Speelberg, B., Buiting, A. G. M., Kooij, M. V. M., Ruys, G. J. H. M., Vincent, H. H., Vermeulen, M., Olink, A. G., & Hoepelman, I. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1233 · Cited by 35
Comparative trial of four antibiotic combinations for perforated appendicitis in children.
Çiftçi, A. Ö., Tanyel, F. C., Büyükpamukçu, N., & Hiçsönmez, A. (1997) · PubMed · Cited by 32
Guerrero, M. F., Arnau, C., Valdés, L., Vallvé, C., Gudiol, F., & Rodríguez-Torres, A. (1991) · Infection · doi:10.1007/bf01715772 · Cited by 30
Mouton, Y., Deboscker, Y., Bazin, C., et al. (1990) · PubMed · Cited by 30
Saleh‐Mghir, A., Crémieux, A., Vallois, J. M., Muffat‐Joly, M., Devine, C., & Carbon, C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2403 · Cited by 28
Chaudhary, M., Shrivastava, S., Varughese, L., et al. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408784293660 · Cited by 26
Cefepime for infections of the biliary tract.
Thompson, J. E., Bennion, R. S., Roettger, R., Lally, K. P., Hopkins, J. A., & Wilson, S. E. (1993) · PubMed · Cited by 24
A comparative study of two antibiotic regimens for the treatment of operative site infections
Duff, P., Keiser, J. F., & Strong, S. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90782-7 · Cited by 21
Sedgwick, P. M. (2010) · BMJ · doi:10.1136/bmj.c1825 · Cited by 18
Leibovici, L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.006 · Cited by 15
Self-citationKljucar, S., Heimesaat, M., von Pritzbuer, E., et al. (1987) · Infection · doi:10.1007/bf01645868 · Cited by 14
Figueroa-Damián, R., Zesati, R. V., Martín-Herrasti, J. M. S., et al. (1996) · PubMed · Cited by 5
Cited by
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Metadata
- Authors
- Paul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-01-07
- Volume
- 2018
- Issue
- 12
- Pages
- CD003344-CD003344
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2128169890
- Cited by
- 377
- References
- 82
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.